Search

everythinglearnresearchcommunity

for

Search:↓

Squalene-based carriers improve delivery of a treatment to hair follicles for alopecia areata.

High-dose intravenous iron therapy doesn't interfere with treatment improvements in IBD patients with iron deficiency anemia.

2.5 mg/day finasteride effectively treats female pattern hair loss.

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

The new dutasteride gel improves hair growth for treating baldness.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Adding diltiazem to a beta blocker can cause dangerously slow heart rates.

2.5 mg/mL TAC is as effective and safe as 5 mg/mL, but 5 mg/mL may improve hair regrowth and density more.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

Finasteride, a drug that changes testosterone to a different hormone, was studied and its effects over time were modeled successfully.

Dutasteride reduces hospitalization and prostate cancer risk compared to finasteride, potentially offsetting its higher cost.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

The FDA rejected a testosterone drug again due to safety concerns.

The conclusion is that cerebrovascular diseases can cause seizure-like activity in stroke patients, which can be improved with antiepileptic drugs.

Lecithin-encapsulated resveratrol nanoparticles could be a safe and effective anti-cancer treatment.

A reliable method was developed to measure aristolochic acid-I in rat blood.

The decision board effectively helps lupus nephritis patients in Brazil choose treatments by clearly presenting options and side effects.

DPCP can help regrow hair in some people with severe alopecia.

Media coverage led to more dermatologists prescribing low-dose oral minoxidil for hair loss.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Combining low-level laser therapy and exosome therapy promotes hair growth.

Low-dose oral minoxidil helps improve hairline and eyebrow coverage in frontal fibrosing alopecia.

The FDA approved the first gene therapy for a blood disorder after overcoming early challenges and demonstrating patient benefits.

A man with severe leprosy developed painless ulcers and numbness, treated successfully with multiple drugs and vitamins.

Higher doses of 5α-reductase inhibitors may lower mortality risk, but low doses increase it.

The document suggests that severe hair loss in SLE patients may be an early sign of scalp DLE, treatable with immunosuppressive therapy.

Hair loss in SLE patients is mostly due to chronic telogen effluvium and is linked to moderate disease activity.

Chronic DHEA supplementation slightly increases testosterone in hair but stays within safe limits.

Dutasteride effectively treats benign prostatic obstruction, improves urinary flow, reduces prostate size, and may prevent prostate cancer, but can cause sexual side effects.